Patent ID: 9597311
Date: 2017-03-21
CPC Classifications: A61K,A61P

Claim:
1. A method of treatment which minimizes the risks associated with a malignant cancer tumor by suppressing the development of any existing cancer tumor, comprising treating a human, a canine, or a feline, including humans, canines, and felines known to either have a cancer tumor or who have had an exposure to a carcinogen or who have a genetic disposition to form cancer tumors, said method of treatment comprising administering, either separately or together, effective amounts of betaine or its homologs in which one or more of the methyl groups attached to the nitrogen atom are replaced by ethyl or isopropyl groups, and vitamin C, at least 10 mg/kg of body weight each per day, until there is no more risk of damage from the cancer tumor and wherein said treatment is combined with one or more known anti-cancer treatments where the treatments are sequential.